Related Experiment Video

Updated: Jul 13, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Left ventricular restoration: how important is the surgical treatment of ischemic heart failure trial?

Lorenzo Menicanti1, Marisa Di Donato

  • 1San Donato Hospital, San Donato Milanese, Milano, Italy. menicanti@libero.it <menicanti@libero.it>

Heart Failure Clinics
|July 24, 2007
PubMed

Insights

The Surgical Treatment of Ischemic Heart Failure (STICH) trial may show surgery is better than medicine for heart failure. If confirmed, this could lead to more aggressive testing for coronary artery disease and bypass surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Ischemic heart failure presents a significant clinical challenge.
  • Current treatment paradigms for heart failure often focus on medical management.
  • The role of revascularization in ischemic heart failure remains a critical area of investigation.

Purpose of the Study:

  • To evaluate the potential impact of the Surgical Treatment of Ischemic Heart Failure (STICH) trial results.
  • To determine if surgical therapy is superior to medical therapy for ischemic heart failure.
  • To assess the implications for early aggressive evaluation of coronary artery disease.

Main Methods:

  • The abstract discusses a hypothetical outcome of the STICH trial.
  • It implies a comparison between surgical and medical treatment strategies.
  • Focus is on the diagnostic and therapeutic implications based on trial results.

Main Results:

  • The STICH trial's findings could establish surgical therapy as a preferred strategy.
  • Confirmation of the revascularization hypothesis is anticipated.
  • This could significantly alter the management of ischemic heart disease.

Conclusions:

  • If surgical therapy proves superior, early, aggressive evaluation for coronary artery disease will be crucial.
  • This approach could transform the treatment landscape for ischemic heart failure.
  • Increased utilization of coronary artery bypass grafting is expected for eligible patients.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...